Stellanin-PEG, 3%, 20 g

100 g of ointment for external use contains: 

Active substance: 

1,3-diethylbenzimidazolium triiodide - 3.0 g;

Excipients: 

povidone (low molecular weight polyvinylpyrrolidone), 

dimexide, 

polyethylene oxide 1500 (polyethylene glycol 1500), 

polyethylene oxide 400 (polyethylene glycol 400).

The mechanism of the pharmacological activity of the drug is the antibacterial action of 1.3-diethylbenzimidazolium. 

Active iodine, which is a part of 1.3-diethylbenzimidazolium triiodide, inactivates the proteins of the bacterial wall and enzyme proteins of bacteria, thereby exerting a bactericidal effect on microorganisms. The pronounced antimicrobial effect of the drug prevents wound infection.

Along with antibacterial and anti-inflammatory effects, the ointment has a high osmotic potential, which is especially important in the treatment of purulent wounds, because promotes the evacuation of purulent discharge from the wound defect.

Pharmacokinetics

Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.

• Treatment of acute purulent processes (wounds) of the skin and soft tissues (boils, carbuncles, hydroadenitis, phlegmon, abscesses);
• additional treatment of purulent complications of postoperative wounds (after excision, coagulation, episiotomy, for the treatment of cracks in the skin, wounds and sutures);
• thermal lesions of the skin and soft tissues of I-III degrees, complicated by the infectious process;
• trophic ulcers, bedsores, complicated by the infectious process.
• abrasions, cuts, scrapes, cracks, scratches.

It is forbidden to take Stellanin-PEG in the first trimester of pregnancy.

Take with caution in the II and III trimesters of pregnancy and during lactation.

• Hypersensitivity to the components of the Stellanin-PEG preparation,
• thyrotoxicosis,
• adenoma of the thyroid gland,
• severe renal failure
• simultaneous therapy with radioactive iodine,
• children under 18 years old,
• I trimester of pregnancy.

With care: chronic renal failure, II and III trimesters of pregnancy, lactation.

In rare cases, allergic skin reactions (itching, flushing of the skin) are possible, in the event of which the drug should be discontinued.

Do not use Stellanin-PEG in combination with other antiseptic agents containing mercury, oxidants, alkalis and cationic surfactants.

An alkaline or acidic environment, the presence of fat, pus, blood weaken the antiseptic activity.

The ointment is applied in a thin layer of about 1.5-2 mm directly to the wound surface, after which a sterile gauze bandage is applied or the drug is applied to the dressing material, and then to the wound. The ointment layer should exceed the circumference of the wound by at least 5 mm. 

Tampons soaked in ointment loosely fill the cavities of purulent wounds after their surgical treatment, and gauze turundas with the drug are injected into the fistulous passages. When the wound is localized in an inconvenient place for bandaging, it is permissible to use an adhesive or adhesive bandage.

Dressings are changed 1-2 times a day.

The daily dose should not exceed 10 g. The duration of treatment is on average 5 - 15 days.

For minor skin lesions (abrasions, cuts, scratches, cracks, scratches), the drug is applied in a thin layer to the affected surface 2 times a day.

Overdose cases are not described.

If you accidentally take the drug inside, you may experience nausea and vomiting.

It is necessary to rinse the stomach and consult a doctor, if necessary, symptomatic treatment is performed.

Avoid getting the ointment in the eyes.

In case of contact with the eyes, rinse with warm water.

Ointment for external use.